KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacira BioSciences (PCRX) Operating Expenses (2016 - 2025)

Pacira BioSciences has reported Operating Expenses over the past 16 years, most recently at $194.5 million for Q4 2025.

  • Quarterly results put Operating Expenses at $194.5 million for Q4 2025, up 19.68% from a year ago — trailing twelve months through Dec 2025 was $707.2 million (down 8.67% YoY), and the annual figure for FY2025 was $707.2 million, down 8.67%.
  • Operating Expenses for Q4 2025 was $194.5 million at Pacira BioSciences, up from $173.2 million in the prior quarter.
  • Over the last five years, Operating Expenses for PCRX hit a ceiling of $308.1 million in Q3 2024 and a floor of $96.3 million in Q3 2021.
  • Median Operating Expenses over the past 5 years was $151.8 million (2024), compared with a mean of $156.4 million.
  • Biggest five-year swings in Operating Expenses: skyrocketed 110.73% in 2024 and later tumbled 43.8% in 2025.
  • Pacira BioSciences' Operating Expenses stood at $155.0 million in 2021, then increased by 17.33% to $181.8 million in 2022, then decreased by 18.57% to $148.1 million in 2023, then increased by 9.77% to $162.5 million in 2024, then rose by 19.68% to $194.5 million in 2025.
  • The last three reported values for Operating Expenses were $194.5 million (Q4 2025), $173.2 million (Q3 2025), and $172.6 million (Q2 2025) per Business Quant data.